Bharat Biotech, a company based in Hyderabad, said on Saturday that the potential of its vaccine Covaxin can only be ascertained after the second dose. The company said that its clinical trials are based on a two-dose program, with a difference of 18 days. Cleanliness on behalf of the company has come in the case of finding Corona positive test after giving a dose of Covaxin by Haryana Health Minister Aniv Vij. Vij was given a shot about two weeks ago under the clinical trial of the vaccine.
The biotechnology company said in a statement that the Covaxin clinical trials are based on a two-dose program. The vaccine potential is known 14 days after the second dose. According to the statement, the vaccine works after receiving both doses. The company further said that 50 percent of the participants were given vaccine as a trial, while others were given placebo. In Phase 3 trial, 50 percent people were given vaccine, while the remaining 50 percent got placebo.
Source: www.financialexpress.com